129 related articles for article (PubMed ID: 11502663)
1. Association of p53 gene mutation and telomerase activity in resectable non-small cell lung cancer.
Maniwa Y; Yoshimura M; Obayashi C; Inaba M; Kiyooka K; Kanki M; Okita Y
Chest; 2001 Aug; 120(2):589-94. PubMed ID: 11502663
[TBL] [Abstract][Full Text] [Related]
2. Analysis of mutant p53 and telomerase activity in non-small cell lung cancer.
Kiyooka K; Maniwa Y; Okada M
Ann Thorac Cardiovasc Surg; 1999 Oct; 5(5):293-9. PubMed ID: 10550714
[TBL] [Abstract][Full Text] [Related]
3. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
Huang C; Taki T; Adachi M; Konishi T; Higashiyama M; Miyake M
Oncogene; 1998 May; 16(19):2469-77. PubMed ID: 9627113
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of mutation types of p53 gene and possible carcinogenic factors in lung cancer].
Gao ZQ; Gao Z; Zhang X
Zhonghua Yu Fang Yi Xue Za Zhi; 1997 Mar; 31(2):88-91. PubMed ID: 9812619
[TBL] [Abstract][Full Text] [Related]
5. Telomerase activity in non-small cell lung carcinomas correlates with smoking status.
Xinarianos G; Scott FM; Liloglou T; Prime W; Callaghan J; Gosney JR; Field JK
Int J Oncol; 1999 Nov; 15(5):961-5. PubMed ID: 10536180
[TBL] [Abstract][Full Text] [Related]
6. [Detection of p53 gene mutation in bronchial biopsy samples from lung cancer patients with polymerase chain reaction-single strand conformation polymorphism-silver staining method].
Zhu Z; Li L; Zhu Y
Zhonghua Nei Ke Za Zhi; 1996 Nov; 35(11):738-40. PubMed ID: 9592339
[TBL] [Abstract][Full Text] [Related]
7. High frequency of frameshift mutation on p53 gene in Taiwanese with non small cell lung cancer.
Chang MY; Chong IW; Chen FM; Wang JY; Cheng TL; Cheng YJ; Sheu CC; Hung SY; Yang MC; Lin SR
Cancer Lett; 2005 May; 222(2):195-204. PubMed ID: 15863268
[TBL] [Abstract][Full Text] [Related]
8. Comparison of oncogene mutation detection and telomerase activity for the molecular staging of non-small cell lung cancer.
Ahrendt SA; Yang SC; Wu L; Westra WH; Jen J; Califano JA; Sidransky D
Clin Cancer Res; 1997 Jul; 3(7):1207-14. PubMed ID: 9815801
[TBL] [Abstract][Full Text] [Related]
9. Telomerase activity and p53 gene mutation in familial polyposis coli.
Ikeguchi M; Makino M; Kaibara N
Anticancer Res; 2000; 20(5C):3833-7. PubMed ID: 11268463
[TBL] [Abstract][Full Text] [Related]
10. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
[TBL] [Abstract][Full Text] [Related]
11. P53 expression, p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis.
Chang KW; Sarraj S; Lin SC; Tsai PI; Solt D
Carcinogenesis; 2000 Jul; 21(7):1441-51. PubMed ID: 10874024
[TBL] [Abstract][Full Text] [Related]
12. p53 gene mutations in non-small cell lung cancer detected by polymerase chain reaction single-strand conformation polymorphism analysis.
Zhao Y; Wu D; Xiang X; Zhang B; Zhou N; Hu Y
Chin Med Sci J; 1999 Sep; 14(3):134-7. PubMed ID: 12903811
[TBL] [Abstract][Full Text] [Related]
13. Telomerase activity and expression of the telomerase catalytic subunit gene in non-small cell lung cancer: correlation with decreased apoptosis and clinical prognosis.
Wang J; Liu X; Jiang W; Liang L
Chin Med J (Engl); 2000 Nov; 113(11):985-90. PubMed ID: 11776132
[TBL] [Abstract][Full Text] [Related]
14. Mutations of the p53 gene as a predictor of poor prognosis in patients with non-small-cell lung cancer.
Mitsudomi T; Oyama T; Kusano T; Osaki T; Nakanishi R; Shirakusa T
J Natl Cancer Inst; 1993 Dec; 85(24):2018-23. PubMed ID: 8246288
[TBL] [Abstract][Full Text] [Related]
15. Topoisomerase IIalpha gene expression is regulated by the p53 tumor suppressor gene in nonsmall cell lung carcinoma patients.
Liu D; Huang CL; Kameyama K; Hayashi E; Yamauchi A; Sumitomo S; Yokomise H
Cancer; 2002 Apr; 94(8):2239-47. PubMed ID: 12001123
[TBL] [Abstract][Full Text] [Related]
16. [Expression and significance of telomerase reverse transcriptase and its regulators in non-small cell lung carcinoma].
Chen TX; Xiong YY; Liu L
Ai Zheng; 2004 Mar; 23(3):273-7. PubMed ID: 15025956
[TBL] [Abstract][Full Text] [Related]
17. Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer.
Metzger R; Vallbohmer D; Müller-Tidow C; Higashi H; Bollschweiler E; Warnecke-Eberz U; Brabender J; Baldus SE; Xi H; Berdel WE; Serve H; Hoelscher AH; Schneider PM
Anticancer Res; 2009 Apr; 29(4):1157-62. PubMed ID: 19414359
[TBL] [Abstract][Full Text] [Related]
18. p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features.
Mitsudomi T; Steinberg SM; Nau MM; Carbone D; D'Amico D; Bodner S; Oie HK; Linnoila RI; Mulshine JL; Minna JD
Oncogene; 1992 Jan; 7(1):171-80. PubMed ID: 1311061
[TBL] [Abstract][Full Text] [Related]
19. Telomerase activity in primary and secondary glioblastomas multiforme as a novel molecular tumor marker.
Harada K; Kurisu K; Tahara H; Tahara E; Ide T; Tahara E
J Neurosurg; 2000 Oct; 93(4):618-25. PubMed ID: 11014540
[TBL] [Abstract][Full Text] [Related]
20. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]